Page last updated: 2024-08-21

zinc oxide and maltodextrin

zinc oxide has been researched along with maltodextrin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baena-Ocampo, L; Cano-Colín, S; Cruz-Castañeda, O; De la Garza, A; Elizondo-Vázquez, F; Krötzsch, E; Pat, L; Salgado, RM	1

Other Studies

1 other study(ies) available for zinc oxide and maltodextrin

Article	Year
Maltodextrin/ascorbic acid stimulates wound closure by increasing collagen turnover and TGF-β1 expression in vitro and changing the stage of inflammation from chronic to acute in vivo. Journal of tissue viability, 2017, Volume: 26, Issue:2 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Case-Control Studies; Collagen Type III; Drug Combinations; Female; Humans; Longitudinal Studies; Lower Extremity; Male; Middle Aged; Pilot Projects; Polysaccharides; Prospective Studies; Random Allocation; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Varicose Ulcer; Wound Healing; Zinc Oxide	2017

Article

Year

Maltodextrin/ascorbic acid stimulates wound closure by increasing collagen turnover and TGF-β1 expression in vitro and changing the stage of inflammation from chronic to acute in vivo.

Journal of tissue viability, 2017, Volume: 26, Issue:2

Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Case-Control Studies; Collagen Type III; Drug Combinations; Female; Humans; Longitudinal Studies; Lower Extremity; Male; Middle Aged; Pilot Projects; Polysaccharides; Prospective Studies; Random Allocation; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Varicose Ulcer; Wound Healing; Zinc Oxide

2017